Comparison of liquid chromatography-ultraviolet and chromatography-tandem mass spectrometry for the determination of indapamide in human whole blood and their applications in bioequivalence studies

Abstract The aim of this study was to compare two methods which were based on liquid chromatography with ultraviolet detection (LC-UV) and liquid chromatography-tandem mass spectrometry (LC-MS/MS), respectively, to determine indapamide (CAS 26807-65-8) and to apply them to bioequivalence studies. The universal parameters, including selectivity, linearity, precision, and quantification limit, served as gold standard for the comparison of the two methods. As a result, the two methods were both very consistent and reliable. Furthermore, the LC-MS/MS method required only one-fifth the blood volume needed by the other method and was approximately 25 times more sensitive than the other method. The total run time of the LC-MS/MS method was 3.5 min per sample as opposed to 11 min for the other method. Forty healthy male Chinese volunteers were selected as subjects. One half were orally administrered 2.5 mg indapamide immediate release tablets while the other half were orally administered 1.5 mg indapamide sustained release coated tablets. The collected blood samples were determined with the two methods described above. The pharmacokinetic parameters were determined using a noncompartmental method. For the bioequivalence studies, the pharmacokinetic parameters acquired here were in line with the literature and parameters met the criteria set by the State Food and Drug Administration of China (SFDA) for bioequivalence study, indicating that generic drugs are bioequivalent to branded drugs. The present study suggests that the two methods based on LC-UV and LC-MS/MS were suitable for bioavailability studies of indapamide with different pharmaceutical formulations. Consequently, it can be believed that the criterion that each individual expected concentration range would need a given bioassay with the requested sensitivity is not absolutely right. In practice, most of the time, the highest sensitivity allows to bioassay concentrations in a higher range.

[1]  A. Wen,et al.  Simultaneous determination of lansoprazole and its metabolites 5'-hydroxy lansoprazole and lansoprazole sulphone in human plasma by LC-MS/MS: application to a pharmacokinetic study in healthy volunteers. , 2008, Journal of pharmaceutical and biomedical analysis.

[2]  T. Makino,et al.  Determination of indapamide in human serum using 96-well solid-phase extraction and high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS). , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  A. Marzo,et al.  Tandem Mass Spectrometry (LC-MS-MS): a Predominant Role in Bioassays for Pharmacokinetic Studies , 2007, Arzneimittelforschung.

[4]  L. Ding,et al.  A sensitive LC-ESI-MS method for the determination of indapamide in human plasma: method and clinical applications. , 2006, Journal of pharmaceutical and biomedical analysis.

[5]  Guangji Wang,et al.  Simple, Sensitive, and Rapid LC–MS Method for the Quantitation of Indapamide in Human Plasma—Application to Pharmacokinetic Studies , 2006 .

[6]  P. Shrivastav,et al.  Liquid chromatography-tandem mass spectrometry validated method for the estimation of indapamide in human whole blood. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  Ming-na Song,et al.  A selective HPLC method for the determination of indapamide in human whole blood: application to a bioequivalence study in Chinese volunteers. , 2006, Journal of pharmaceutical and biomedical analysis.

[8]  V. David,et al.  Liquid chromatography-electrospray tandem mass spectrometry method for determination of indapamide in serum for single/multiple dose bioequivalence studies of sustained release formulations. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  T. Stafilov,et al.  Optimization of a solid-phase extraction method for determination of indapamide in biological fluids using high-performance liquid chromatography. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  R. Alonso,et al.  Quantitative determination of indapamide in pharmaceuticals and urine by high-performance liquid chromatography with amperometric detection. , 1999, Journal of chromatographic science.

[11]  M. Lalande,et al.  High-performance liquid chromatographic method for the determination of indapamide in human whole blood. , 1993, Journal of chromatography.

[12]  D. Chen [Determination of indapamide in human serum by high performance liquid chromatography]. , 1990, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

[13]  P. Grebow,et al.  High-performance liquid chromatographic analysis of indapamide (RHC 2555) in urine, plasma and blood. , 1982, Journal of chromatography.

[14]  P. Pietta,et al.  High-performance liquid chromatographic assay for monitoring indapamide and its major metabolite in urine. , 1982, Journal of Chromatography A.

[15]  G. Pabst,et al.  Bioavailability and pharmacokinetics of a fixed combination of delapril/indapamide following single and multiple dosing in healthy volunteers , 2010, European Journal of Drug Metabolism and Pharmacokinetics.

[16]  L. Borghi,et al.  [Determination of indapamide in plasma by HPLC]. , 1986, Bollettino chimico farmaceutico.